{
    "data": [
        {
            "id": "69038c26ecb8a70001459c9d",
            "title": "Earnings Outlook For Interface",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Interface (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TILE\" target=\"_blank\">TILE</a>) will release its quarterly earnings report on Friday, 2025-10-31. Here's a brief overview for investors ahead of the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts anticipate Interface to report an <strong>earnings per share</strong> (EPS) of $0.47.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Anticipation surrounds Interface's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p><!--/$--><!--$--><h3 class=\"block core-block\">Past Earnings Performance</h3><!--/$--><!--$--><p class=\"block core-block\">The company's EPS beat by $0.13 in the last quarter, leading to a 0.0% drop in the share price on the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Interface's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-gQfuga iaHpuj\"></div><!--/$--><!--$--><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNzAwIiBoZWlnaHQ9IjUwMCIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB2ZXJzaW9uPSIxLjEiLz4=\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 700px, (min-width: 800px) 700px\" src=\"https://www.benzinga.com/files/images/story/2025/1761840166_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761840166_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=750 1x, https://www.benzinga.com/files/images/story/2025/1761840166_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><h3 class=\"block core-block\">Stock Performance</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of Interface were trading at $26.57 as of October 29. Over the last 52-week period, shares are up 15.12%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Analyst Observations about Interface</h3><!--/$--><!--$--><p class=\"block core-block\">For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Interface.</p><!--/$--><!--$--><p class=\"block core-block\">The consensus rating for Interface is Outperform, based on 3 analyst ratings. With an average one-year price target of $32.0, there's a potential 20.44% upside.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Peer Ratings Overview</h3><!--/$--><!--$--><p class=\"block core-block\">The following analysis focuses on the analyst ratings and average 1-year price targets of  and ACCO Brands, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p><!--/$--><!--$--><ul class=\"block core-block\">\n<li>Analysts currently favor an Outperform trajectory for ACCO Brands, with an average 1-year price target of $6.0, suggesting a potential 77.42% downside.</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">Peer Metrics Summary</h3><!--/$--><!--$--><p class=\"block core-block\">Within the peer analysis summary, vital metrics for  and ACCO Brands are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">Key Takeaway:</p><!--/$--><!--$--><p class=\"block core-block\">Interface outperforms its peers in revenue growth and gross profit, ranking at the top for both metrics. However, it lags behind in return on equity, placing in the middle compared to its peers.</p><!--/$--><!--$--><h3 class=\"block core-block\">Discovering Interface: A Closer Look</h3><!--/$--><!--$--><p class=\"block core-block\">Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.</p><!--/$--><!--$--><h3 class=\"block core-block\">Interface: Financial Performance Dissected</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Revenue Growth:</strong> Interface's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2025, the company achieved a revenue growth rate of approximately <strong>8.33%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> Interface's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>8.67%,</strong> the company showcases strong profitability and effective cost management.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> Interface's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>5.99%,</strong> the company showcases efficient use of equity capital and strong financial health.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> Interface's ROA excels beyond industry benchmarks, reaching <strong>2.64%</strong>. This signifies efficient management of assets and strong financial health.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> Interface's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.68</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/TILE/earnings\" target=\"_blank\"><strong>To track all earnings releases for Interface visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/earnings/25/10/48534534/earnings-outlook-for-interface",
            "pub_date": "2025-10-31 00:02:50",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69038c46ecb8a70001459cb4",
            "title": "Bitcoin Sells Trump-Xi Deal, Fed Rate Cut: Is A Breakdown To $93,000 Next?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Bitcoin </strong>(CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/btc/usd\" target=\"_blank\">BTC</a>) is trading below $108,000 after the Federal Reserve's 25-basis-point rate cut failed to lift markets, with charts <a href=\"https://www.benzinga.com/money/bitcoin-price-prediction-oct-14\" target=\"_blank\">pointing to deeper losses</a>.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Fed Rate Cut Fails To Wake Up Bitcoin Price</h3><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The Federal Reserve reduced interest rates by 25 basis points to a range of 3.75%–4.00%, marking its first cut in months. </p><!--/$--><!--$--><p class=\"block core-block\">The move, widely expected, reflected policymakers attempt to balance slowing inflation with emerging economic weakness. </p><!--/$--><!--$--><p class=\"block core-block\">Despite the policy shift, markets barely <a href=\"https://x.com/Cointelegraph/status/1983700432145793098\" target=\"_blank\">reacted</a>, as traders had already priced in the decision ahead of Wednesday's announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts said the muted response stemmed from expectations that the Fed would act cautiously through year-end. </p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">U.S. equities traded mixed, with the <strong>S&amp;P 500</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/SPY\" target=\"_blank\">SPY</a>) flat at 6,890, <strong>Dow Jones</strong> slipping 0.16%, and the <strong>Nasdaq Composite</strong> up 0.55%.</p><!--/$--><!--$--><p class=\"block core-block\">10-year Treasury yields edged to 4.10% and the global crypto market cap fell 4.2% to $3.64 trillion.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Powell's Warning Rattles Markets And Crypto Traders</h3><!--/$--><!--$--><p class=\"block core-block\">Following the meeting, Fed Chair <strong>Jerome Powell</strong> emphasized that another rate cut in December \"is not a foregone conclusion,\" highlighting deep divisions within the Federal Open Market Committee.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">In a post on X, <strong>Quinn Thompson</strong>, chief investment officer at <strong>Lekker Capital</strong>, <a href=\"https://x.com/qthomp/status/1983656245371531553\" target=\"_blank\">described</a> Powell's language as \"political posturing\" aimed at pushing the administration to reopen the government. </p><!--/$--><!--$--><p class=\"block core-block\">Thompson argued that Powell's message effectively warned that a continued shutdown could block key economic data and hinder future rate decisions.</p><!--/$--><!--$--><p class=\"block core-block\">The shift in tone rattled markets briefly, with Treasury yields climbing and the probability of a December cut falling from near certainty to roughly even odds. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Crypto assets mirrored the cautious sentiment, with <strong>Ethereum </strong>(CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/eth/usd\" target=\"_blank\">ETH</a>) down to $3,773 and <strong>XRP</strong> (CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/xrp/usd\" target=\"_blank\">XRP</a>) slipping to $2.45.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Liquidity Shift Could Be Hidden Bullish Fuel For Bitcoin</h3><!--/$--><!--$--><p class=\"block core-block\">Thompson said Powell's comments should not be viewed as a hawkish turn but as leverage in a political negotiation. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">He noted that the Fed will halt its quantitative tightening program on Dec. 1, ending the runoff of Treasury and mortgage holdings. </p><!--/$--><!--$--><p class=\"block core-block\">Instead, the central bank will reinvest maturing securities into Treasury bills, which he framed as \"incrementally liquidity positive.\"</p><!--/$--><!--$--><p class=\"block core-block\">Analysts see that as a supportive signal for risk assets, especially cryptocurrencies, which tend to benefit from easier dollar liquidity. </p><!--/$--><!--$--><p class=\"block core-block\">The mix of cooling inflation, labor-market softness, and a pause in balance-sheet contraction creates an environment historically favorable for digital assets.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Bitcoin Price Breakdown Puts $93,000 Support In The Spotlight</h3><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://in.tradingview.com/symbols/BTCUSD/\" target=\"_blank\"><em>BTC Price Action (Source: TradingView)</em></a></p><!--/$--><!--$--><p class=\"block core-block\">On the charts, bitcoin has slipped under $108,000, breaking down from a multi-week symmetrical triangle. </p><!--/$--><!--$--><p class=\"block core-block\">The rejection near the EMA cluster between $111,700 and $112,900 confirmed selling pressure. </p><!--/$--><!--$--><p class=\"block core-block\">Momentum remains weak, with the RSI near 30, suggesting the asset is approaching oversold conditions but not yet primed for reversal.</p><!--/$--><!--$--><p class=\"block core-block\">The next major support sits at $102,000–$100,000, followed by a critical zone around $93,000–$92,000 — the final major base from August. </p><!--/$--><!--$--><p class=\"block core-block\">A failure to defend this area could expose Bitcoin to deeper losses toward $90,000. </p><!--/$--><!--$--><p class=\"block core-block\">Bulls would need a recovery above $112,000 to neutralize the breakdown and restore short-term momentum.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48534555\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/news/politics/25/10/48519309/trump-concludes-amazing-meeting-with-xi-jinping-teases-pretty-soon-trade-deal\" target=\"_blank\">Trump Concludes ‘Amazing’ Meeting With Xi Jinping, Teases ‘Pretty Soon’ Trade Deal</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/A-Futuristic-Digital-themed-Illustration.jpeg",
            "link": "https://www.benzinga.com/crypto/cryptocurrency/25/10/48534555/bitcoin-sells-trump-xi-deal-fed-rate-cut-is-a-breakdown-to-93000-next",
            "pub_date": "2025-10-31 00:03:23",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69038d30ecb8a70001459d40",
            "title": "Ambev&#39;s Q3 Profit Jumps 8.7% Y/Y, Shares Gain On Higher Margins And Buyback",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Ambev SA</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ABEV\" target=\"_blank\">ABEV</a>) shares traded higher on Thursday after the company reported <a href=\"https://www.benzinga.com/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">third-quarter FY25 results</a>.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Details</h2><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Ambev reported quarterly earnings of 24 cents per share in Brazilian Reals (4 cents per share in USD), up 8.7% year over year (Y/Y), driven by lower taxes.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported quarterly sales of 20.8 billion Brazilian Real ($3.826 billion), which declined 5.7% Y/Y.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: </em></strong><em><a href=\"https://www.benzinga.com/markets/commodities/25/06/45766967/us-aluminum-tariffs-risk-supply-chain-and-food-security-industry-insiders-warn\" rel=\"noreferrer noopener\" target=\"_blank\">US Aluminum Tariffs Risk Supply Chain And Food Security, Industry Insiders Warn</a></em></p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">Normalized EBITDA, meanwhile, increased by 2.9% Y/Y organically, and margins expanded 50 basis points, led by disciplined cost and expense management and efficient resource allocation.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><p class=\"block core-block\">Net revenue per hectoliter (NR/hl) grew by 7.4%, contributing to overall net revenue increases <a href=\"https://www.sec.gov/Archives/edgar/data/1565025/000129281425003688/abevpr3q25_6k.htm\" rel=\"noreferrer noopener\" target=\"_blank\">in </a>most business units: Brazil non-alcoholic beverages (NAB) rose by 0.5%, Caribbean (CAC) by 2.2% and Latin America South (LAS) by 9.2%, while Canada and Brazil Beer saw a decline of 0.1% and 2.1%, respectively, due to volume decreases.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Organically, volumes declined 5.8% Y/Y mainly due to unseasonable weather and a challenging environment in key markets. By Segment, volumes fell in Brazil Beer (-7.7% Y/Y), Brazil NAB (-8.6% Y/Y), Canada (-2.0% Y/Y), and LAS (-0.8% Y/Y).</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Other Key Metrics</h2><!--/$--><!--$--><p class=\"block core-block\">The Board of Directors approved a share repurchase program of up to 208 million shares, valued at about 2.5 billion Brazilian Reals based on the October 29, 2025, closing price, to be executed over the next 18 months.</p><!--/$--><!--$--><p class=\"block core-block\">As of September 30, cash and cash equivalents (less bank overdrafts) stood at 18.31 billion Brazilian Real.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action:</strong> ABEV shares are up 5.28% at $2.295 at the last check on Thursday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48534693\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/latin-america/25/06/45937801/latin-americas-hot-stocks-3-nyse-picks-to-dodge-trade-wars-mideast-mayhem\" rel=\"noreferrer noopener\" target=\"_blank\">Latin America’s Hot Stocks: 3 NYSE Picks To Dodge Trade Wars, Mideast Mayhem</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Ambev--SA.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48534693/ambevs-q3-profit-jumps-8-7-y-y-shares-gain-on-higher-margins-and-buyback",
            "pub_date": "2025-10-31 00:07:16",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "690386b2ecb8a70001459871",
            "title": "Pfizer Blasts Novo Nordisk&#39;s $9 Billion Counteroffer For Metsera As &#39;Reckless&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">On Thursday, <strong>Metsera Inc</strong>. (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MTSR\" target=\"_blank\">MTSR</a>) received an <a href=\"https://www.benzinga.com/topic/mergers-and-acquisitions\" target=\"_blank\">unsolicited acquisition proposal </a>from <strong>Novo Nordisk A/S</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVO\" target=\"_blank\">NVO</a>).</p><!--/$--><!--$--><p class=\"block core-block\">Metsera said the proposal constitutes a “Superior Company Proposal” as defined in Metsera’s existing Merger Agreement with <strong>Pfizer Inc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/PFE\" target=\"_blank\">PFE</a>).</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">In September, Pfizer agreed to acquire Metsera for $47.50 per share in cash, representing an enterprise value of <a href=\"https://www.benzinga.com/m-a/25/09/47787042/pfizer-tries-to-revitalize-obesity-portfolio-with-5-billion-matsera-deal\" rel=\"noreferrer noopener\" target=\"_blank\">approximately $4.9 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The acquisition brings a portfolio of differentiated oral and injectable incretin, non-incretin, and combination therapy candidates.</p><!--/$--><!--$--><p class=\"block core-block\">Novo Nordisk’s proposal is structured in two steps.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>In the first step, immediately following the signing of a definitive agreement, Novo Nordisk would pay <a href=\"https://www.benzinga.com/pressreleases/25/10/n48522694/metsera-receives-unsolicited-proposal-from-novo-nordisk\" rel=\"noreferrer noopener\" target=\"_blank\">Metsera $56.50 per share</a> in cash, as well as certain amounts related to Metsera employee equity and transaction expenses.</li>\n<li>In exchange, Metsera would issue Novo Nordisk non-voting preferred stock representing 50% of Metsera’s share capital.</li>\n<li>On the same day, Metsera would declare a dividend of $56.50 per Metsera common share, payable in cash, to be distributed 10 days later.</li>\n</ul><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">In the second step, which would happen only after receiving approval from Metsera shareholders and relevant regulators, Metsera shareholders would receive a contingent value right representing up to $21.25 per share in cash based on development and regulatory approval milestones.</p><!--/$--><!--$--><p class=\"block core-block\">This proposal values Metsera at up to $77.75 per share, for approximately $9 billion.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer, in a press release on Thursday, stated that it is aware of Novo Nordisk’s proposal, which it considers<a href=\"https://www.benzinga.com/pressreleases/25/10/b48522228/pfizer-addresses-proposal-for-metsera\" target=\"_blank\"> “reckless and unprecedented.”</a></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Pfizer stated that it is an attempt by a company with a dominant market position to suppress competition in violation of the law by acquiring an emerging American challenger.</p><!--/$--><!--$--><p class=\"block core-block\">It is also structured in a way that circumvents antitrust laws and carries substantial regulatory and operational risks.</p><!--/$--><!--$--><p class=\"block core-block\">The proposal is illusory and cannot qualify as a superior proposal under Pfizer’s agreement with Metsera.</p><!--/$--><!--$--><p class=\"block core-block\">Pfizer is prepared to pursue all legal avenues to enforce its rights under the agreement.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">As disclosed in Metsera’s proxy, the Board of Metsera previously rejected Novo Nordisk’s proposal due to “a variety of risks” in its deal structure. The Board chose Pfizer over other bidders because none “could complete an acquisition of 100% of Metsera’s equity with the same level of certainty or on the same expected timeline as Pfizer.”</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: MTSR stock is up 21.03% at $63.19, and NVO stock is down 2.31% at $50.19 at the last check on Thursday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/markets/earnings/25/10/48519623/alphabets-ai-bet-delivers-record-100-billion-quarter-cloud-backlog-surges-to-155-billion\" rel=\"noreferrer noopener\" target=\"_blank\">Alphabet’s AI Bet Delivers Record $100 Billion Quarter, Cloud Backlog Surges To $155 Billion</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: jittawit21/Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48533502\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Genetic-Research-And-Biotech-Science-Con.jpeg",
            "link": "https://www.benzinga.com/m-a/25/10/48533502/pfizer-blasts-novo-nordisks-9-billion-counteroffer-for-metsera-as-reckless",
            "pub_date": "2025-10-30 23:39:34",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69038822ecb8a700014599bd",
            "title": "Here&#39;s How Much You Would Have Made Owning Howmet Aerospace Stock In The Last 5 Years",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">Howmet Aerospace (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/HWM\" target=\"_blank\">HWM</a>) has outperformed the market over the past 5 years by 47.18% on an annualized basis producing an average annual return of 62.49%. Currently, Howmet Aerospace has a market capitalization of $85.18 billion. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>Buying $1000 In HWM:</strong> If an investor had bought $1000 of HWM stock 5 years ago, it would be worth <strong>$11,820.73</strong> today based on a price of $211.00 for HWM at the time of writing.</p><!--/$--><!--$--><h3 class=\"block core-block\">Howmet Aerospace's Performance Over Last 5 Years</h3><!--/$--><!--$--><div class=\"sc-feVKPA LhjAx core-image flex items-center justify-center\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img alt=\"\" aria-hidden=\"true\" src=\"data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMTUwMCIgaGVpZ2h0PSI4MDAiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"/></span><img alt=\"\" decoding=\"async\" loading=\"lazy\" src=\"data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/><noscript><img alt=\"\" decoding=\"async\" fetchpriority=\"low\" loading=\"lazy\" sizes=\"(max-width: 800px) 1500px, (min-width: 800px) 1500px\" src=\"https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840\" srcset=\"https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=1920 1x, https://www.benzinga.com/files/images/story/2025/1761839139_0.png?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=3840 2x\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"/></noscript></span></div><!--/$--><!--$--><p class=\"block core-block\">Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--><!--$--><div class=\"sc-jWAYhW dvGDGG\"></div><!--/$--></div></div>",
            "image": "",
            "link": "https://www.benzinga.com/insights/news/25/10/48533825/heres-how-much-you-would-have-made-owning-howmet-aerospace-stock-in-the-last-5-years",
            "pub_date": "2025-10-30 23:45:42",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}